
Sign up to save your podcasts
Or
In this week's episode, we'll be comparing BTK inhibitors in relapsed/refractory CLL. Then, we'll hear how researchers in the UK unraveled the genetic background of the AnWj blood group. Finally we'll learn about the role of BCL-2 and BAFF in CLL cell survival following venetoclax therapy.
Featured Articles:
4.1
4848 ratings
In this week's episode, we'll be comparing BTK inhibitors in relapsed/refractory CLL. Then, we'll hear how researchers in the UK unraveled the genetic background of the AnWj blood group. Finally we'll learn about the role of BCL-2 and BAFF in CLL cell survival following venetoclax therapy.
Featured Articles:
129 Listeners
71 Listeners
319 Listeners
26 Listeners
489 Listeners
273 Listeners
2 Listeners
186 Listeners
362 Listeners
3 Listeners
2 Listeners
29 Listeners
165 Listeners
48 Listeners
1 Listeners